Abstract

The prevalence of mitral valve prolapse (MVP) among middle- and older-aged individuals is estimated to be 2–4% in Western countries. However, few studies have been conducted among Asian individuals and young adults. This study included a sample of 2442 consecutive military adults aged 18–39 years in Hualien, Taiwan. MVP was defined as displacement of the anterior or posterior leaflet of the mitral valve to the mid portion of the annular hinge point > 2 mm in the parasternal long-axis view of echocardiography. Cardiac chamber size and wall thickness were measured based on the latest criteria of the American Society of Echocardiography. The clinical features of participants with MVP and those without MVP were compared using a two-sample t test, and the cardiac structures were compared using analysis of covariance with adjustment for body surface area (BSA). Eighty-two participants were diagnosed with MVP, and the prevalence was 3.36% in the overall population. Compared with those without MVP, participants with MVP had a lower body mass index (kg/m2) (24.89 ± 3.70 vs. 23.91 ± 3.45, p = 0.02) and higher prevalence of somatic symptoms related to exercise (11.0% vs. 4.9%, p = 0.02) and systolic click in auscultation (18.3% vs. 0.6%, p < 0.01). In addition, participants with MVP had greater left ventricular mass (gm) and smaller right ventricular wall thickness (mm) and dimensions (mm) indexed by BSA than those without MVP (149.12 ± 35.76 vs. 155.38 ± 36.26; 4.66 ± 0.63 vs. 4.40 ± 0.68; 26.57 ± 3.99 vs. 25.41 ± 4.35, respectively, all p-values < 0.01). In conclusion, the prevalence and clinical features of MVP in military young adults in Taiwan were in line with those in Western countries. Whether the novel MVP phenotype found in this study has any pathological meaning needs further investigation.

Details

Title
Prevalence and characteristics of mitral valve prolapse in military young adults in Taiwan of the CHIEF Heart Study
Author
Pang-Yen, Liu 1 ; Tsai Kun-Zhe 2 ; Yen-Po, Lin 3 ; Chin-Sheng, Lin 1 ; Huan-Chang, Zeng 4 ; Takimoto Eiki 5 ; Gen-Min, Lin 6 

 Tri-Service General Hospital and National Defense Medical Center, Division of Cardiology, Department of Internal Medicine, Taipei, Taiwan (GRID:grid.260565.2) (ISNI:0000 0004 0634 0356) 
 Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578) 
 Taipei Tzu Chi General Hospital, Department of Critical Care Medicine, New Taipei City, Taiwan (GRID:grid.414692.c) (ISNI:0000 0004 0572 899X) 
 Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578); GENEUS Medical Technology Co., New Taipei City, Taiwan (GRID:grid.413601.1) 
 University of Tokyo, Department of Cardiovascular Medicine, School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Tri-Service General Hospital and National Defense Medical Center, Division of Cardiology, Department of Internal Medicine, Taipei, Taiwan (GRID:grid.260565.2) (ISNI:0000 0004 0634 0356); Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578); Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2484414582
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.